Andrew E Sloan

9PUBLICATIONS
94CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targetsPredictive and prognostic markersGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 08, 2025
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Jun 05, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.

Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz

|Dec 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.

Andrew E Sloan, Charles J Nock, Xiaobu Ye

|Feb 21, 2021
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review.

Clark Chen, Ian Lee, Claudio Tatsui

Pageof 2